The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.
Targeted study participants are Black and Hispanic patients with a history of stroke and a current systolic blood pressure (BP) above JNC7 recommended range (\>=140 mmHg) who recently entered home care service. The NP only program will provide a 30 day intervention while the NP/HC team will provide 3 months of support via in-home and telephone encounters for patients randomized to one of these groups. In the first 30 days post-enrollment the NP will focus on medical case management and coordination with primary care providers and specialists, provide self-management coaching, and intervene if gaps in care are identified - all with a focus on BP reduction and preparing the patient for ongoing BP maintenance. As applicable, the HC will pick up the case after 30 days and follow up with the plan of care jointly established by the patient, NP and HC. The focus will be on ongoing self-management coaching, providing preparation support for physician visits, and linking patient to additional community resources, as needed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
495
Visiting Nurse Service of New York
New York, New York, United States
Reduction of systolic blood pressure
Patients randomized to the NP only and the NP+HC transitional care interventions will have greater 3 and 12 month reduction in SBP than patients in Usual Home Care.
Time frame: Baseline to 3 and 12 months.
Cost-effectiveness of NP-only and NP+HC relative to UHC
Both interventions will be more costly but more cost-effective than usual home care.
Time frame: VNSNY home care admission to 3 and 12 months post admission
Influence on post-stroke patients' function and health-related quality of life (QoL)
Both interventions will yield significant comparative improvements in function and health-related QoL; NP+HC will be more effective than NP-only.
Time frame: Baseline to 3 and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.